Skip to content
  • ABOUT
        • MISSION/HISTORY
        • DIRECTORS/STAFF
        • SUPPORT
        • INTERNSHIPS
        • FINANCIAL INFORMATION
        • JOBS
        • CONTACT US
  • WASTEWATCHER
  • MEDIA
        • COMMENTARY
        • PRESS RELEASES
        • VIDEOS
  • ISSUES
    • CONGRESSIONAL PIG BOOK
      • EARMARK DATABASE
      • PRIME CUTS
      • ISSUE BRIEFS
      • AGENCY COMMENTS
    • DEFENSE
      • AVIATION & SPACE
      • F-35 JOINT STRIKE FIGHTER
      • PROCUREMENT
    • INNOVATION & TECHNOLOGY POLICY CENTER
      • ANTITRUST
      • ARTIFICIAL INTELLIGENCE
      • BIOPHARMACEUTICALS
      • INTELLECTUAL PROPERTY
      • PRIVACY
      • TECHNOLOGY AND INNOVATION
      • TELECOMMUNICATIONS
    • GENERAL WASTE
      • AGRICULTURE REFORM
      • POSTAL SERVICE
      • TAXES
      • TRANSPORTATION
    • HEALTH AND SCIENCE
      • PRICE CONTROLS
      • GOVERNMENT RUN HEALTHCARE
      • 340B DRUG DISCOUNT PROGRAM
      • PHARMACY BENEFIT MANAGERS
      • TOBACCO HARM REDUCTION
    • STATE ISSUES
  • ITPC
        • ANTITRUST
        • ARTIFICIAL INTELLIGENCE
        • BIOPHARMACEUTICALS
        • INTELLECTUAL PROPERTY
        • PRIVACY
        • TECHNOLOGY AND INNOVATION
        • TELECOMMUNICATIONS
  • CCAGW
DONATE
Facebook X-twitter Icon-instagram-1 Icon-youtube

Intellectual Property

No Government Price Controls to Pay for Biden’s Gargantuan Spending Bill
Elizabeth Wright

No Government Price Controls to Pay for Biden’s Gargantuan Spending Bill

Elizabeth Wright July 22, 2021
President Biden's Executive Order Will Harm Rather than Promote Competition
Thomas Schatz

President Biden’s Executive Order Will Harm Rather than Promote Competition

Thomas Schatz July 10, 2021
Elizabeth Wright

Biden Trips Badly on Intellectual Property in TRIPS

Elizabeth Wright May 7, 2021
Thomas Schatz

All Nations Must Respect and Protect Intellectual Property Rights

Thomas Schatz April 27, 2021
Elizabeth Wright

Bernie is Back with More Bad Bills

Elizabeth Wright April 1, 2021
Most Favored Nation Policy Is Unfavorable to U.S. Biopharmaceutical Research
Elizabeth Wright

Most Favored Nation Policy Is Unfavorable to U.S. Biopharmaceutical Research

Elizabeth Wright November 20, 2020
« Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Next »
  • ANTITRUST
  • ARTIFICIAL INTELLIGENCE
  • BIOPHARMACEUTICALS
  • INTELLECTUAL PROPERTY
  • PRIVACY
  • TECHNOLOGY AND INNOVATION
  • TELECOMMUNICATIONS
  • ANTITRUST
  • ARTIFICIAL INTELLIGENCE
  • BIOPHARMACEUTICALS
  • INTELLECTUAL PROPERTY
  • PRIVACY
  • TECHNOLOGY AND INNOVATION
  • TELECOMMUNICATIONS


    Citizens Against Government Waste works to eliminate waste, fraud, abuse, and mismanagement in government through research and public education.

    • ABOUT
    • WASTEWATCHER
    • MEDIA CENTER
    • ISSUES
    • ITPC
    • CCAGW
    • 1-800-USA-DEBT ®
    • MEDIA@CAGW.ORG
    • 317 MASSACHUSETTS AVENUE, N.E.
      SUITE 300
      WASHINGTON, D.C. 20002

    © Citizens Against Government Waste